Medical Devices Australia

Australia Prenatal Genetic Testing Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Australia Prenatal Genetic Testing Market Industry Trends and Forecast to 2034: Segmented by (Test, Condition, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Australia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $66.8 Mn Placeholder estimate
Estimate 2025 $74.5 Mn 1.1% of the global market
Projected 2034 $196.7 Mn 164.2% Adds $122.3 Mn over 9 forecast years
CAGR 2025–2034 11.4% Faster than 61% of 173 Medical Devices markets here
Key players 5
  • Australia is 1.12% of the global market.
  • In APAC, the largest is China at $609.1 Mn.
  • Fastest growing: India at 13.4% a year.
  • Australia ranks 4th of 10 by size in APAC.

Market size projection

Australia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$122.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Prenatal Genetic Testing Market market size by year, Australia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $66.8 Mn — —
2025 (base) $74.5 Mn +$7.6 Mn —
2026 (forecast) $82.9 Mn +$8.5 Mn +11.4%
2027 (forecast) $92.4 Mn +$9.5 Mn +24.1%
2028 (forecast) $102.9 Mn +$10.5 Mn +38.2%
2029 (forecast) $114.7 Mn +$11.7 Mn +54%
2030 (forecast) $127.7 Mn +$13.1 Mn +71.6%
2031 (forecast) $142.3 Mn +$14.6 Mn +91.1%
2032 (forecast) $158.5 Mn +$16.2 Mn +112.9%
2033 (forecast) $176.6 Mn +$18.1 Mn +137.2%
2034 (forecast) $196.7 Mn +$20.1 Mn +164.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $6.66 Bn
  2. North America $3.24 Bn
  3. US $2.81 Bn
  4. APAC $1.50 Bn
  5. Europe $1.22 Bn
  6. China $609.1 Mn
  7. Canada $596.3 Mn
  8. Japan $359.1 Mn
  9. Latin America $295.0 Mn
  10. Germany $271.6 Mn
  11. Middle East $237.5 Mn
  12. Brazil $187.2 Mn
  13. France $162.9 Mn
  14. Italy $154.2 Mn
  15. UK $145.1 Mn
  16. Ecuador $126.2 Mn
  17. Saudi Arabia $124.0 Mn
  18. India $122.7 Mn
  19. Africa $117.8 Mn
  20. Spain $108.4 Mn
  21. Mexico $96.9 Mn
  22. Australia (this report) $74.5 Mn
  23. New Zealand $68.2 Mn
  24. Russia $64.5 Mn
  25. South Africa $38.2 Mn
  26. UAE $30.4 Mn
  27. Egypt $21.2 Mn
  28. Philippines $16.7 Mn
  29. Hong Kong $12.4 Mn
  30. Malaysia $10.0 Mn
  31. Thailand $8.5 Mn
  32. Singapore $7.0 Mn
  33. Kenya $4.7 Mn

Report snapshot

Australia Prenatal Genetic Testing Market Analysis at a glance
Market size, 2025$74.5 Mn placeholder estimate
Forecast, 2034$196.7 Mn placeholder estimate
Growth (CAGR), 2025–203411.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, condition and end user (see all)
Key playersIllumina, Inc., Natera, BGI Genomics, Roche Diagnostics, Myriad Genetics, Inc. (see all)
Regulator in AustraliaTGASource: Therapeutic Goods Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Australia Prenatal Genetic Testing Market Analysis Executive Summary

Prenatal genetic tests, such as non-invasive prenatal tests, check a baby's DNA for genetic conditions during pregnancy, often from the mother's blood.

Key segments of the prenatal Genetic Testing market include test (NIPT, Carrier Screening and Amniocentesis Testing) and condition (Down Syndrome, Sex Chromosome Disorders and Microdeletions).

Bar chart: Australia Prenatal Genetic Testing market size, 2024–2034, placeholder estimates. $66.8 Mn in 2024, $74.5 Mn in 2025 and $196.7 Mn in 2034, 11.4% CAGR.
Australia Prenatal Genetic Testing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Australia Prenatal Genetic Testing Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the prenatal Genetic Testing market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the prenatal Genetic Testing market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the prenatal Genetic Testing market.

Competitive Landscape for Prenatal Genetic Testing Market in Australia

The prenatal Genetic Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Prenatal Genetic Testing Market in Australia

Prenatal Genetic Testing in Australia: rules and payment

Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied.⁠[1] Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines.⁠[2]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how prenatal Genetic Testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Australia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Prenatal Genetic Testing right now, from free public sources.

Latest research 242 papers since 2021 (worldwide)

  1. Measuring the Utility of Prenatal Exome Sequencing Using the Clinician-Reported Genetic Testing Utility InDEx for Prenatal Care: A Retrospective Multicentre Study. Prenatal diagnosis, 2026
  2. Case Report: Prenatal and postnatal clinical manifestations of 15q duplication syndrome: a single longitudinal case combined with pooled analysis of 35 prenatal cases. Frontiers in medicine, 2026
  3. Case Report: Short rib-thoracic dysplasia type 3 presenting with predominant respiratory manifestations. Frontiers in pediatrics, 2026
  4. Prenatal Sonographic Features of Heterozygous DLL1 Single-Nucleotide Variants and 6q27 Deletions: A Single Referral Center Retrospective Case Series. Prenatal diagnosis, 2026
  5. Opportunistic Prenatal Genetic Testing During Fetoscopic Laser Surgery for Twin-Twin Transfusion Syndrome. Prenatal diagnosis, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Prenatal Genetic Testing in context

Australia compared

  • Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 15 countries we cover in APAC.[1]
  • Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 18.1% of people (2025). World: 10.4% of people (2025). 3rd highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Prenatal Genetic Testing market in Australia?
Placeholder estimate: about $74.5 Mn in 2025, rising to about $196.7 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Prenatal Genetic Testing market in Australia growing?
Placeholder estimate: about 11.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Prenatal Genetic Testing market report cover?
The report splits the market by test (NIPT, Carrier Screening, Amniocentesis Testing, CVS Testing), condition (Down Syndrome, Sex Chromosome Disorders, Microdeletions) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Prenatal Genetic Testing market?
Key players include Illumina, Inc., Natera, BGI Genomics, Roche Diagnostics and Myriad Genetics, Inc..
What is driving the Prenatal Genetic Testing market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the prenatal Genetic Testing market.
Who regulates Prenatal Genetic Testing in Australia?
Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied. Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
How is healthcare paid for in Australia?
Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines. Source: Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
How much research is published on Prenatal Genetic Testing?
PubMed lists 242 papers on Prenatal Genetic Testing added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Prenatal Genetic Testing in Australia? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Women's Health Supplements: A Growing FocusAnaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth… Iron Supplements and the Fight Against AnaemiaIron supplements are the first line against anaemia. Why taking them is the hard part, and how the market is… Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Australia

See all
Same topic, other categories

Related on diagnostics and lab testing and maternal

See the topic